Connor, Clark & Lunn Investment Management (CC&L)’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,215
| Closed | -$1.41M | – | 1226 |
|
|
2022
Q1 | $1.41M | Sell |
3,215
-615
| -16% | -$269K | 0.01% | 592 |
|
|
2021
Q4 | $1.68M | Sell |
3,830
-271
| -7% | -$119K | 0.01% | 573 |
|
|
2021
Q3 | $2.28M | Buy |
+4,101
| New | +$2.28M | 0.01% | 501 |
|
|
2015
Q2 | – | Sell |
-306
| Closed | -$111K | – | 671 |
|
|
2015
Q1 | $111K | Buy |
+306
| New | +$111K | ﹤0.01% | 531 |
|